Erratum: Aspirin better than clopidogrel on major adverse cardiovascular events reduction after ischemic stroke: A retrospective nationwide cohort study (PLoS ONE (2019) 14: 8 (e0221750) DOI: 10.1371/journal.pone.0221750)

Amelia Nur Vidyanti, Lung Chan, Cheng Li Lin, Chih Hsin Muo, Chung Y. Hsu, You Chia Chen, Dean Wu, Chaur Jong Hu

研究成果: 雜誌貢獻評論/辯論同行評審

1 引文 斯高帕斯(Scopus)

摘要

After publication of this article [1], the authors contacted PLOS ONE to clarify that they did not obtain prospective institutional review board approval to conduct their study. Upon editorial review and consultation with the Academic Editor, it was determined that the article meets the journal's standards for ethical oversight and that approval by an ethics committee was not necessary given that all data analyzed in the study were fully anonymized prior to access and analysis by the authors. In light of this update, the final two sentences of the second paragraph in the Study design and population subsection of the Materials and methods are incorrect. The correct sentence is: All data analyzed in the study were fully anonymized prior to access and analysis by the authors. © 2020 Vidyanti et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
原文英語
文章編號e0232016
期刊PLoS ONE
15
發行號4
DOIs
出版狀態已發佈 - 4月 2020

ASJC Scopus subject areas

  • 多學科

指紋

深入研究「Erratum: Aspirin better than clopidogrel on major adverse cardiovascular events reduction after ischemic stroke: A retrospective nationwide cohort study (PLoS ONE (2019) 14: 8 (e0221750) DOI: 10.1371/journal.pone.0221750)」主題。共同形成了獨特的指紋。

引用此